All Type of News
Domestic pharmaceutical companies have poured out 42 generics of Baraclude just in this year
Domestic pharmaceutical companies have shown interests in type B hepatitis treatments.
According to the Ministry of Food and Drug Safety, generics of ‘Baraclude (entecavir),’ which were first introduced by BMS Korea ...
Pressure of the government and the pharmaceutical industry gave the pharmaceutical distribution industry a dilemma
The Korea Pharmaceutical Distribution Association is caught in a dilemma over the affiliated-company of Hanmi Pharm, Online Pharm. Having difficulties to find a solution, the association seems to be deeply concerned a...
It will be obligated to report ‘serial numbers’ for every shipment of complete pharmaceutical products from next January
As scheduled, the government decided to force pharmaceutical companies to make supply reports including serial numbers for shipment of complete pharmaceutical products in January next year.
The plan is to be capable ...
Restasis, expiring in its patent on the 17th, has shaken up the xerophthalmia market
Restasis(cyclosporine, Allergan Korea), which is well known as the first xerophthalmia treatment in the world, has shaken up the market as it will be expired in its patent on the 17th of this month.
Domestic companie...
Green Cross Holdings invested in an American bio venture to develop gene therapyGreen Cross Holdings (President Byung-geon Lee) announced on the 14th that it has participated in the Series B-2 Round of the American bio venture ‘Juventas Therapeutics(hereina...
|
Why did Takeda select GeoYoung and Dongwon Pharmaceutical Wholesale?As launching Actinum, Takeda has come forward with distribution not with domestic pharmaceutical companies, but typical wholesalers such as GeoYoung and Dongwon Pharmaceutical W...
|
The number of medical institutions increased 1.95% up compared to the year before while the one of pharmacies was increased by 0.80% last year
It is observed that the number of medical institutes increased 1,658 units (1.95%) up over the last year to 86,629 units in 2014.
The Health Insurance Review & Assessment Service (Chairperson Myung-sae Sohn, HIRA) an...
Will GSK escape from misfortune in its vaccine business?GSK, which used be called the strong but has had difficulties in vaccine, is planning to announce its ambitious work after a long time.
The GSK’s ambitious work is the shingles...
|
Will the notice of the Relvar Ellipta benefit reorganize asthma inhalants to once a day?
As the asthma treatment to inhale only once a day is expected to be available next month, the industry has carefully paid attention on potential competition for the treatment.
On the last December, the Ministry of He...
The size of the domestic CRO market is KRW 280 billion, leading growth of the foreign market
It is observed that the domestic CRO (Contract Research Organization) industry has been expanded by the rise of new clinical trials. The total sales of the CRO industry exceeded KRW 280 billion last year.
On the 27th...
